Utilization Pattern of Mineralocorticoid Receptor Antagonists in Contemporary Patients Hospitalized With Acute Decompensated Heart Failure: A Single-Center Experience-Reference-Cited by-同舟云学术

Utilization Pattern of Mineralocorticoid Receptor Antagonists in Contemporary Patients Hospitalized With Acute Decompensated Heart Failure: A Single-Center Experience

Published:2014-04 Issue:4 Volume:20 Page:229-235
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Chamsi-Pasha Mohammed A.^ORCID,Dupont Matthias^ORCID,Al Jaroudi Wael A.,Tang W. H. Wilson^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. The effect of spironolactone on morbidity and mortality in patients with severe heart failure;Pitt;N Engl J Med,1999

2. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

3. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

4. Aldosterone receptor antagonists: effective but often forgotten;Maron;Circulation,2010

5. Use of aldosterone antagonists in heart failure;Albert;JAMA,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study;BMC Cardiovascular Disorders;2019-08-09

2. New treatments for hyperkalaemia: clinical use in cardiology;European Heart Journal Supplements;2019-02-01

3. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization – a Review;Reviews in Cardiovascular Medicine;2019

4. Obesity-Associated Heart Failure as a Theoretical Target for Treatment With Mineralocorticoid Receptor Antagonists;JAMA Cardiology;2018-09-01

5. Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists;European Journal of Heart Failure;2018-04-18